health
February 5, 2026
Novo Nordisk says it will take legal action after Hims & Hers reveals $49 copy of Wegovy pill
Hims said it would sell a copy of the newly launched weight loss pill for $49, far less than the $149 Novo sells the branded pill for.
TL;DR
- Novo Nordisk is suing Hims & Hers for releasing a cheaper copycat of its Wegovy weight loss pill.
- Novo Nordisk alleges illegal compounding by Hims & Hers, posing risks to patient safety and infringing on intellectual property.
- Hims & Hers asserts its compounded product is "personalized" and legal, despite using the same active ingredient as Wegovy.
- The announcement led to a nearly 7% drop in Novo Nordisk and Eli Lilly shares.
- Hims & Hers plans to offer the oral semaglutide copy for $49 for the first month and $99 thereafter.
- Novo Nordisk previously ended a partnership with Hims & Hers due to concerns over deceptive marketing and patient safety.
Continue reading the original article